IOL Chemicals And Pharmaceuticals Ltd.
Snapshot View

374.80 +8.50 ▲2.3%

06 October 2022, 04:01:00 PM
Volume: 17,999

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://iolcp.com
Market Cap 2,200.28 Cr.
Enterprise Value(EV) 2,053.44 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 22.75 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 16.48 Trailing Twelve Months Ending 2022-06
Industry PE 32.09 Trailing Twelve Months Ending 2022-06
Book Value / Share 242.76 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.54 Calculated using Price: 374.80
Dividend Yield 1.07 Period Ending 2022-03
No. of Shares Subscribed 5.87 Cr. 58,705,502 Shares
FaceValue 10
Company Profile
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.32%
1 Week
+8.25%
1 Month
+1.39%
3 Month
+13.61%
6 Month
-25.92%
1 Year
-38.65%
2 Year
-51.99%
5 Year
+675.18%
10 Year
+1208.20%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.85 -34.14 -20.72 2.50 13.70 69.54 56.93 43.06 12.50
Return on Capital Employed (%) 11.48 -2.78 3.68 11.57 15.03 55.53 68.09 54.20 17.16
Return on Assets (%) 0.45 -9.24 -5.43 0.59 3.34 25.50 30.66 28.69 8.78

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 173 209 207 185 189 216 474 814 1,260 1,390
Non Curr. Liab. 326 255 286 304 294 280 211 80 59 57
Curr. Liab. 229 277 209 283 328 351 325 454 433 575
Minority Int.
Equity & Liab. 727 742 702 772 811 847 1,010 1,347 1,752 2,022
Non Curr. Assets 476 460 418 416 396 416 458 499 600 882
Curr. Assets 251 281 283 357 415 431 552 848 1,152 1,141
Misc. Exp. not W/O
Total Assets 727 742 702 772 811 847 1,010 1,347 1,752 2,022

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 564 385 580 711 983 1,685 1,894 1,967 2,184 2,231
Other Income 1 1 1 1 6 10 16 24 32 31
Total Income 565 386 582 712 990 1,696 1,910 1,991 2,216 2,262
Total Expenditure -468 -373 -529 -608 -864 -1,276 -1,321 -1,375 -1,928 -2,028
PBIDT 97 13 53 103 126 420 590 616 288 234
Interest -60 -59 -61 -68 -64 -51 -21 -6 -8 -10
Depreciation -32 -29 -30 -30 -30 -32 -36 -39 -43 -44
Taxation -2 9 -1 -1 -4 -99 -172 -127 -57 -46
Exceptional Items -14
PAT 3 -67 -40 5 28 237 361 445 166 134
Adjusted EPS 1 -14 -7 1 5 42 64 76 28 23

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 53 78 -47 18 83 120 273 471 380 91
Cash Fr. Inv. -18 -12 -5 -27 -23 -50 -63 -184 -317 -120
Cash Fr. Finan. -32 -66 50 9 -60 -70 -197 -272 -58 -2
Net Change 3 1 -2 0 1 -1 13 15 4 -31
Cash & Cash Eqvt 14 15 13 1 2 1 13 28 32 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 43.69 43.69 43.69 43.69 43.69 43.69 43.69 43.69 43.69
Public 56.31 56.31 56.31 56.31 56.31 56.31 56.31 56.31 56.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 03 Oct 2022
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Company has registered with REACH Certificate for Ethyl Acetate (CAS: 141-7-86) with a tonnage band of > 1000 TPA in accordance with EU REACH Regulation on Chemicals and their Safe Use.
Thu, 29 Sep 2022
Closure of Trading Window
Notice of closure of trading window
Thu, 22 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015

Technical Scans View Details >>

Tue, 04 Oct 2022
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 3 Months High Increase 3 Months
High Decrease 1 Year High Decrease 1 Year
High Increase 5 Years High Increase 5 Years
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 226,077.34 954.00 +1.2%
Divi's Laboratories Ltd. 100,349.78 3,735.70 -1.2%
Cipla Ltd. 92,377.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,445.07 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,140.16 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 53,880.51 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,512.57 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.13 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 32.32 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 37.12 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.27 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.62 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.51 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 8.07 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.30 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.63 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.43 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.53 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On IOL Chemicals And Pharmaceuticals Ltd.

What is IOL Chem & Pharma share price?

Can I buy IOL Chem & Pharma shares now?

What is the Dividend Yield of IOL Chem & Pharma?

What is the Market Cap of IOL Chem & Pharma?

What are the key metrics to analyse IOL Chem & Pharma?

What is the 52 Week High and Low of IOL Chem & Pharma?

What is the trend of IOL Chem & Pharma share price?